Seelos Therapeutics, Inc. (SEEL)
USD 0.37
(-31.49%)
USD 0.37
(-31.49%)
| Breakdown | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 |
|---|---|---|---|---|---|---|
| Revenue | 2.2 Million | - | - | - | 375 Thousand | - |
| Cost of Revenue | 57 Thousand | 53 Thousand | - | - | 22.56 Million | - |
| Gross Profit | 2.14 Million | -53 Thousand | - | - | -22.18 Million | - |
| Operating Expenses | 12.58 Million | 70.91 Million | 61.66 Million | 18.75 Million | 29.74 Million | 9.14 Million |
| Selling, General and Administrative Expenses | 12.52 Million | 12.29 Million | 15.02 Million | 7.77 Million | 7.55 Million | 7.92 Million |
| Research and Development Expenses | 30.11 Million | 58.62 Million | 46.64 Million | 10.98 Million | 22.56 Million | 1.22 Million |
| Other Expenses | -30.11 Million | -3.01 Million | 230 Thousand | - | -375 Thousand | 1000.00 |
| Cost and Expenses | 42.7 Million | 70.91 Million | 61.66 Million | 18.75 Million | 29.74 Million | 9.14 Million |
| Operating Income | -40.49 Million | -70.91 Million | -61.66 Million | -18.75 Million | -29.74 Million | -9.14 Million |
| Interest Expense | 75 Thousand | 14 Thousand | 1.59 Million | 164 Thousand | 29 Thousand | - |
| Income Tax Expense | - | 2.6 Million | 1.48 Million | 119 Thousand | -497 Thousand | -70 Thousand |
| Earnings before Tax | -37.88 Million | -73.53 Million | -66.04 Million | -19.1 Million | -50.88 Million | -9.21 Million |
| Net Income | -37.88 Million | -76.13 Million | -67.53 Million | -19.22 Million | -50.38 Million | -9.24 Million |
| Earnings Per Share Basic | -7.73 | -21.48 | -22.29 | -12.88 | -74.43 | -89.97 |
| Earnings Per Share Diluted | -7.73 | -21.48 | -22.29 | -12.88 | -74.43 | -89.97 |
| Weighted Average Shares Outstanding | 4.9 Million | 3.54 Million | 3.02 Million | 1.49 Million | 676.96 Thousand | 102.71 Thousand |
| Weighted Average Shares Outstanding (Diluted) | 4.9 Million | 3.54 Million | 3.02 Million | 1.49 Million | 676.96 Thousand | 102.71 Thousand |
| Gross Margin | 0.97 | - | - | - | -59.17 | - |
| EBIT Margin | -17.14 | - | - | - | -78.21 | - |
| Profit Margin | -17.20 | - | - | - | -134.35 | - |
| EBITDA | -37.75 Million | -73.46 Million | - | - | -29.33 Million | -3.14 Million |
| Earnings Before Tax Margin | -18.38 | - | - | - | -79.33 | - |
| Breakdown | 2024 Q2 | 2024 Q1 | 2023 FY | 2023 Q4 | 2023 Q3 | 2023 Q2 |
|---|---|---|---|---|---|---|
| Revenue | 376 Thousand | 579 Thousand | 2.2 Million | 653 Thousand | 406 Thousand | 336 Thousand |
| Cost of Revenue | 15 Thousand | 15 Thousand | 57 Thousand | 15 Thousand | 14 Thousand | 14 Thousand |
| Gross Profit | 361 Thousand | 564 Thousand | 2.14 Million | 638 Thousand | 392 Thousand | 322 Thousand |
| Operating Expenses | 3.5 Million | 6.61 Million | 42.64 Million | 8.64 Million | 13 Million | 10.95 Million |
| Selling, General and Administrative Expenses | 2.53 Million | 3.09 Million | - | 2.73 Million | 2.98 Million | 2.78 Million |
| Research and Development Expenses | 966 Thousand | 3.52 Million | - | 5.91 Million | 10.02 Million | 8.5 Million |
| Other Expenses | -755 Thousand | -203 Thousand | - | -700 Thousand | -799 Thousand | -616 Thousand |
| Cost and Expenses | 3.51 Million | 6.63 Million | 42.7 Million | 8.66 Million | 13 Million | 10.95 Million |
| Operating Income | -3.13 Million | -6.05 Million | -40.49 Million | -8.01 Million | -12.6 Million | -10.95 Million |
| Interest Expense | 23 Thousand | 23 Thousand | 75 Thousand | 19 Thousand | -42 Thousand | 7000.00 |
| Income Tax Expense | - | -28.27 Thousand | -110.89 Thousand | -1.00 | -14 Thousand | 7000.00 |
| Earnings before Tax | 1.71 Million | -2.66 Million | -37.88 Million | -5.45 Million | 10.49 Million | -29.49 Million |
| Net Income | 1.71 Million | -2.66 Million | -37.88 Million | -5.45 Million | 10.49 Million | -29.49 Million |
| Earnings Per Share Basic | 0.68 | -0.20 | - | -0.56 | 2.33 | -6.71 |
| Earnings Per Share Diluted | 0.12 | -0.20 | - | -0.56 | 2.13 | -6.71 |
| Weighted Average Shares Outstanding | 2.5 Million | 13 Million | 4.9 Million | 9.79 Million | 4.51 Million | 4.39 Million |
| Weighted Average Shares Outstanding (Diluted) | 2.51 Million | 13 Million | 4.9 Million | 9.79 Million | 4.93 Million | 4.39 Million |
| Gross Margin | 0.96 | 0.97 | 0.97 | 0.98 | 0.97 | 0.96 |
| EBIT Margin | -8.31 | -10.43 | - | -12.25 | -31.04 | -32.31 |
| Profit Margin | 4.55 | -4.60 | -17.20 | -8.35 | 25.86 | -87.79 |
| EBITDA | -3.12 Million | -6.04 Million | - | -7.99 Million | -12.6 Million | -10.85 Million |
| Earnings Before Tax Margin | -8.35 | -10.46 | -18.38 | -12.27 | -31.04 | -32.60 |
GDI
XAR
3229
UBCP
SAKUMA
CAR